{
    "other_tests": [
        {
            "procedure_name": "Amniocentesis and Fc-EDA administration",
            "date": "February 2016 (gestational week 26)",
            "findings": "No Fc-EDA detectable in the maternal circulation; genetic testing confirmed hemizygosity for the EDA Y304C mutation.",
            "changes_over_time": "At birth (gestational week 33), treated twins were able to sweat normally, with sustained sweating ability reported at 14 to 22 months of age."
        },
        {
            "procedure_name": "Second Fc-EDA administration",
            "date": "Not specified (gestational week 31)",
            "findings": "Assays of Fc-EDA in amniotic fluid showed no detectable levels before injection.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Amniocentesis and Fc-EDA administration",
            "date": "Not specified (gestational week 26)",
            "findings": "Genetic testing confirmed hemizygosity for the EDA mutation c.924+1dupG (p.V309GfsX8) with healthy prenatal progression after treatment.",
            "changes_over_time": "The treated boy was born at gestational week 39 with normal sweat pore density and Apgar scores of 10."
        }
    ]
}